Clinical Research Directory
Browse clinical research sites, groups, and studies.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-mutant advanced solid tumor types. The study is expected to last approximately 5 years.
Official title: A Phase 1a/1b Trial of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
630
Start Date
2024-09-12
Completion Date
2029-03
Last Updated
2025-12-22
Healthy Volunteers
No
Interventions
LY3962673
Administered orally.
Cetuximab
Administered intravenously.
Gemcitabine
Administered intravenously.
nab-paclitaxel
Administered intravenously.
Oxaliplatin
Administered intravenously.
leucovorin
Administered intravenously.
Irinotecan
Administered intravenously.
5-fluorouracil
Administered intravenously.
Locations (52)
City of Hope
Duarte, California, United States
University of California, Los Angeles (UCLA)
Los Angeles, California, United States
Sarah Cannon Research Institute at HealthOne
Denver, Colorado, United States
Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute
Orlando, Florida, United States
Emory University School of Medicine
Atlanta, Georgia, United States
Community Health Network
Indianapolis, Indiana, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
South Texas Accelerated Research Therapeutics (START) Midwest
Grand Rapids, Michigan, United States
New York University (NYU) Langone Medical Center
New York, New York, United States
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
University of Cincinnati (UC) - Cancer Institute
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
USO - US Oncology Research Network
Nashville, Tennessee, United States
Vanderbilt University School of Medicine
Nashville, Tennessee, United States
MD Anderson Cancer Center
Houston, Texas, United States
South Texas Accelerated Research Therapeutics (START)
San Antonio, Texas, United States
Huntsman Cancer Institute
Salt Lake City, Utah, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States
University of Wisconsin - Carbone Cancer Center
Madison, Wisconsin, United States
The Ottawa Hospital
Ottawa, Canada
Princess Margaret Hospital
Toronto, Canada
Cancer Institute & Hospital, Chinese Academy of Medical Sciences
Beijing, China
Beijing Cancer hospital
Beijing, China
Harbin Medical University Cancer Hospita
Harbin, China
Fudan University Cancer Center
Shanghai, China
Centre Leon Berard
Lyon, France
Centre d'Essais Precoces en Cancerologie de Marseille (CEPCM) - AP-HM Hopital de La Timone
Marseille, France
Oncopole Claudius Regaud
Toulouse, France
Institut Gustave Roussy
Villejuif, France
Charite Universitaetsmedizin Berlin
Berlin, Germany
Universitaetsklinikum Carl Gustav Carus Dresden
Dresden, Germany
Universitaetsklinikum Essen
Essen, Germany
Klinikum der Ludwig-Maximilians-Universitaet Muenchen
München, Germany
START Dublin Early Phase Clinical Trials Unit
Dublin, Ireland
Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli
Naples, Italy
UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
Roma, Italy
Centro Ricerche Cliniche di Verona s.r.l.
Verona, Italy
National Cancer Center Hospital East
Chiba, Japan
Kanagawa cancer center
Kanagawa, Japan
Aichi Cancer Center Hospital
Nagoya, Japan
Kansai Medical University Hospital
Osaka, Japan
National Cancer Center Hospital
Tokyo, Japan
South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos
Barcelona, Spain
Hospital Universitario Vall d'Hebron
Barcelona, Spain
South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain